Hydroxyamine

Hydroxyamine

SCHEMBL250901

NO.ONCc1ccccc1

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.90
THRB P10828 1/20 0.90
MAPT P10636 3/20 0.54
CYP3A4 P08684 2/20 0.54
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALOX12 P18054 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
GAA P10253 2/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
POLB P06746 1/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208455 0.95
Bromide SCHEMBL23360794 0.92 IDO1 (0.94) IDO1THRBMAPTCYP3A4MEN1
Hydrochloric Acid SCHEMBL359448 0.92 IDO1 (0.94) IDO1THRBMAPTCYP3A4MEN1
Ammonia Solution, Strong SCHEMBL4940619 0.92 IDO1 (0.94) IDO1THRBMAPTCYP3A4MEN1
Hydrochloric Acid SCHEMBL27851954 0.90 IDO1 (0.90) IDO1THRBMAPTCYP3A4MEN1
Hydrochloric Acid SCHEMBL8359792 0.90 IDO1 (0.90) IDO1THRBMAPTCYP3A4MEN1
SCHEMBL28863273 0.87 IDO1 (0.85) IDO1THRBMAPTCYP3A4MEN1
Formaldehyde SCHEMBL4447100 0.87 IDO1 (0.85) IDO1THRBMAPTCYP3A4MEN1
Propane SCHEMBL5804162 0.85 IDO1 (0.81) IDO1THRBMAPTCYP3A4MEN1
Toluene SCHEMBL28370603 0.83 IDO1 (0.77) IDO1THRBMAPTCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140045943-A1 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof NAUREX, INC. (US) 2014-02-13 US disclosed
US-20120004309-A1 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof KHAN AMIN (US) 2012-01-05 US disclosed
WO-2010065709-A2 HYDROXAMIC ACID DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF KHAN AMIN (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004309-A1 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof GLS, HGFAC, AADAC IDO1 926/4885THRB 1476/4885MAPT 3690/4885
US-20140045943-A1 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof GLS, HGFAC, AADAC IDO1 926/4885THRB 1476/4885MAPT 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.